Cookies?
Library Header Image
LSE Research Online LSE Library Services

2299P Access to oncology drugs in the UK: are we falling behind Europe after Brexit? A retrospective analysis of regulatory performance and reimbursement for oncology drugs in the UK and Europe (2021-2025)

Khanna, S., Sullivan, R., Lee, R., Krell, J., Jenei, K., Benjamin, D.J., Savage, P. and Lythgoe, M. (2025) 2299P Access to oncology drugs in the UK: are we falling behind Europe after Brexit? A retrospective analysis of regulatory performance and reimbursement for oncology drugs in the UK and Europe (2021-2025). Annals of Oncology, 36 (Supplement 2). S1264. ISSN 0923-7534

Full text not available from this repository.
Identification Number: 10.1016/j.annonc.2025.08.2915
Item Type: Article
Additional Information: © 2025 Published by Elsevier Ltd
Divisions: Health Policy
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RA Public aspects of medicine
Date Deposited: 12 Nov 2025 08:45
Last Modified: 12 Nov 2025 08:45
URI: http://eprints.lse.ac.uk/id/eprint/130128

Actions (login required)

View Item View Item